VC-backed ProNai adds five to senior management staff
ProNAi Therapeutics, a developer of nucleic acid therapeutics, has expanded its senior management team with five additions. Joining the firm are Dr. Angie You as chief business and strategy officer and head of commercial; Wendy Chapman as senior vice president of clinical operations; Chandra Lovejoy as senior vice president of global regulatory affairs and quality; Emma McCann as vice president of program management; and James Smith as vice president of corporate affairs. ProNAi's backers include Vivo Capital, Frazier Healthcare Ventures, OrbiMed Advisors, Adams Street Partners, RA Capital Management, Caxton Alternative Management, Hopen Life Science Ventures, Sectoral Asset Management and Janus Capital Management.
23 October 2014•5 mins read
